NovaBay Pharmaceuticals Inc. (NYSE AMERICAN: NBY)
$2.16
N/A ( 0% ) 38.4K
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically eyecare and skincare products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease. It has two reportable segments: Eyecare and Wound Care and Skincare.
Market Data
Open
$2.16
Previous close
$2.16
Volume
38.4K
Market cap
$2.89M
Day range
$2.13 - $2.19
52 week range
$2.05 - $44.80
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 14 | Mar 26, 2024 |
8-k | 8K-related | 18 | Mar 25, 2024 |
8-k | 8K-related | 18 | Mar 14, 2024 |
8-k | 8K-related | 17 | Jan 10, 2024 |
8-k | 8K-related | 16 | Dec 21, 2023 |
8-k | 8K-related | 14 | Dec 11, 2023 |
10-q | Quarterly Reports | 97 | Nov 09, 2023 |
10-q | Quarterly Reports | 98 | Aug 10, 2023 |
8-k | 8K-related | 13 | Jul 07, 2023 |
8-k | 8K-related | 13 | Jul 06, 2023 |